Skip to main content
Top
Published in: Annals of Surgical Oncology 8/2019

01-08-2019 | Metastasis | Endocrine Tumors

Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group

Authors: Alexandra G. Lopez-Aguiar, MD, MS, Mohammad Y. Zaidi, MD, MS, Eliza W. Beal, MD, Mary Dillhoff, MD, John G. D. Cannon, MD, George A. Poultsides, MD, Zaheer S. Kanji, MD, Flavio G. Rocha, MD, Paula Marincola Smith, MD, Kamran Idrees, MD, Megan Beems, MD, Clifford S. Cho, MD, Alexander V. Fisher, MD, Sharon M. Weber, MD, Bradley A. Krasnick, MD, Ryan C. Fields, MD, Kenneth Cardona, MD, Shishir K. Maithel, MD

Published in: Annals of Surgical Oncology | Issue 8/2019

Login to get access

Abstract

Background

Preoperative factors that reliably predict lymph node (LN) metastases in pancreatic neuroendocrine tumors (PanNETs) are unclear. The number of LNs needed to accurately stage PanNETs has not been defined.

Methods

Patients who underwent curative-intent resection of non-functional PanNETs at eight institutions from 2000 to 2016 were analyzed. Preoperative factors associated with LN metastases were identified. A procedure-specific target for LN retrieval to accurately stage patients was determined.

Results

Of 695 patients who underwent resection, 33% of tumors were proximal (head/uncinate) and 67% were distal (neck/body/tail). Twenty-six percent of patients (n = 158) had LN-positive disease, which was associated with a worse 5-year recurrence-free survival (RFS; 60% vs. 86%; p < 0.001). The increasing number of positive LNs was not associated with worse RFS. Preoperative factors associated with positive LNs included tumor size ≥ 2 cm (odds ratio [OR] 6.6; p < 0.001), proximal location (OR 2.5; p < 0.001), moderate versus well-differentiation (OR 2.1; p = 0.006), and Ki-67 ≥ 3% (OR 3.1; p < 0.001). LN metastases were also present in tumors without these risk factors: < 2 cm (9%), distal location (19%), well-differentiated (23%), and Ki-67 < 3% (16%). Median LN retrieval was 13 for pancreatoduodenectomy (PD), but only 9 for distal pancreatectomy (DP). Given that PD routinely includes a complete regional lymphadenectomy, a minimum number of LNs to accurately stage patients was not identified. However, for DP, removal of less than seven LNs failed to discriminate 5-year RFS between LN-positive and LN-negative patients (less than seven LNs: 72% vs. 83%, p = 0.198; seven or more LNs: 67% vs. 86%; p = 0.002).

Conclusions

Tumor size ≥ 2 cm, proximal location, moderate differentiation, and Ki-67 ≥ 3% are preoperative factors that predict LN positivity in resected non-functional PanNETs. Given the 9–23% incidence of LN metastases in patients without such risk factors, routine regional lymphadenectomy should be considered. PD inherently includes sufficient LN retrieval, while DP should aim to remove seven or more LNs for accurate staging.
Literature
1.
go back to reference Haynes AB, Deshpande V, Ingkakul T, et al. Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes. Arch Surg. 2011;146:534–8CrossRefPubMedPubMedCentral Haynes AB, Deshpande V, Ingkakul T, et al. Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes. Arch Surg. 2011;146:534–8CrossRefPubMedPubMedCentral
2.
go back to reference Strosberg JR, Cheema A, Weber JM, et al. Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications. Ann Surg. 2012;256:321–5CrossRefPubMed Strosberg JR, Cheema A, Weber JM, et al. Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications. Ann Surg. 2012;256:321–5CrossRefPubMed
3.
go back to reference Cherenfant J, Stocker SJ, Gage MK, et al. Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors. Surgery. 2013;154:785–91 (discussion 791–3) CrossRefPubMed Cherenfant J, Stocker SJ, Gage MK, et al. Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors. Surgery. 2013;154:785–91 (discussion 791–3) CrossRefPubMed
4.
go back to reference Postlewait LM, Ethun CG, Baptiste GG, et al. Pancreatic neuroendocrine tumors: preoperative factors that predict lymph node metastases to guide operative strategy. J Surg Oncol. 2016;114:440–5CrossRefPubMed Postlewait LM, Ethun CG, Baptiste GG, et al. Pancreatic neuroendocrine tumors: preoperative factors that predict lymph node metastases to guide operative strategy. J Surg Oncol. 2016;114:440–5CrossRefPubMed
5.
go back to reference Bilimoria KY, Talamonti MS, Tomlinson JS, et al. Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients. Ann Surg. 2008;247:490–500CrossRefPubMed Bilimoria KY, Talamonti MS, Tomlinson JS, et al. Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients. Ann Surg. 2008;247:490–500CrossRefPubMed
7.
go back to reference Ekeblad S, Skogseid B, Dunder K, et al. Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. Clin Cancer Res. 2008;14:7798–803CrossRefPubMed Ekeblad S, Skogseid B, Dunder K, et al. Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. Clin Cancer Res. 2008;14:7798–803CrossRefPubMed
8.
go back to reference Dolan RD, McSorley ST, Horgan PG, et al. Determinants of lymph node count and positivity in patients undergoing surgery for colon cancer. Medicine (Baltimore). 2018;97:e0185CrossRefPubMedPubMedCentral Dolan RD, McSorley ST, Horgan PG, et al. Determinants of lymph node count and positivity in patients undergoing surgery for colon cancer. Medicine (Baltimore). 2018;97:e0185CrossRefPubMedPubMedCentral
9.
go back to reference Reha J, Mukkamalla SKR, Rathore R, et al. Adequate lymph node evaluation in the elderly is associated with improved survival in patients with stage I–III colon cancer: a validation study using the National Cancer Data Base. Eur J Surg Oncol. 2018;44:148–156CrossRefPubMed Reha J, Mukkamalla SKR, Rathore R, et al. Adequate lymph node evaluation in the elderly is associated with improved survival in patients with stage I–III colon cancer: a validation study using the National Cancer Data Base. Eur J Surg Oncol. 2018;44:148–156CrossRefPubMed
10.
go back to reference Lu J, Zheng CH, Cao LL, et al. The effectiveness of the 8th American Joint Committee on Cancer TNM classification in the prognosis evaluation of gastric cancer patients: a comparative study between the 7th and 8th editions. Eur J Surg Oncol. 2017;43:2349–2356CrossRefPubMed Lu J, Zheng CH, Cao LL, et al. The effectiveness of the 8th American Joint Committee on Cancer TNM classification in the prognosis evaluation of gastric cancer patients: a comparative study between the 7th and 8th editions. Eur J Surg Oncol. 2017;43:2349–2356CrossRefPubMed
11.
go back to reference Alatengbaolide, Lin D, Li Y, et al. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes. Am J Clin Oncol. 2013;36:325–30CrossRefPubMed Alatengbaolide, Lin D, Li Y, et al. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes. Am J Clin Oncol. 2013;36:325–30CrossRefPubMed
12.
go back to reference Scarpa A, Mantovani W, Capelli P, et al. Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients. Mod Pathol. 2010;23:824–33CrossRefPubMed Scarpa A, Mantovani W, Capelli P, et al. Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients. Mod Pathol. 2010;23:824–33CrossRefPubMed
13.
go back to reference Hochwald SN, Zee S, Conlon KC, et al. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol. 2002;20:2633–42CrossRefPubMed Hochwald SN, Zee S, Conlon KC, et al. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol. 2002;20:2633–42CrossRefPubMed
14.
go back to reference Sarmiento JM, Farnell MB, Que FG, et al. Pancreaticoduodenectomy for islet cell tumors of the head of the pancreas: long-term survival analysis. World J Surg. 2002;26:1267–71CrossRefPubMed Sarmiento JM, Farnell MB, Que FG, et al. Pancreaticoduodenectomy for islet cell tumors of the head of the pancreas: long-term survival analysis. World J Surg. 2002;26:1267–71CrossRefPubMed
15.
go back to reference Partelli S, Gaujoux S, Boninsegna L, et al. Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs). JAMA Surg. 2013;148:932–9CrossRefPubMed Partelli S, Gaujoux S, Boninsegna L, et al. Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs). JAMA Surg. 2013;148:932–9CrossRefPubMed
16.
go back to reference Tomassetti P, Campana D, Piscitelli L, et al. Endocrine pancreatic tumors: factors correlated with survival. Ann Oncol. 2005;16:1806–10CrossRefPubMed Tomassetti P, Campana D, Piscitelli L, et al. Endocrine pancreatic tumors: factors correlated with survival. Ann Oncol. 2005;16:1806–10CrossRefPubMed
17.
go back to reference Bettini R, Boninsegna L, Mantovani W, et al. Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours. Ann Oncol. 2008;19:903–8CrossRefPubMed Bettini R, Boninsegna L, Mantovani W, et al. Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours. Ann Oncol. 2008;19:903–8CrossRefPubMed
18.
go back to reference Schindl M, Kaczirek K, Kaserer K, et al. Is the new classification of neuroendocrine pancreatic tumors of clinical help? World J Surg. 2000;24:1312–8CrossRefPubMed Schindl M, Kaczirek K, Kaserer K, et al. Is the new classification of neuroendocrine pancreatic tumors of clinical help? World J Surg. 2000;24:1312–8CrossRefPubMed
19.
go back to reference Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67:93–99CrossRefPubMed Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67:93–99CrossRefPubMed
20.
go back to reference Hashim YM, Trinkaus KM, Linehan DC, et al. Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs). Ann Surg. 2014;259:197–203CrossRefPubMedPubMedCentral Hashim YM, Trinkaus KM, Linehan DC, et al. Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs). Ann Surg. 2014;259:197–203CrossRefPubMedPubMedCentral
21.
go back to reference Chin CC, Wang JY, Yeh CY, et al. Metastatic lymph node ratio is a more precise predictor of prognosis than number of lymph node metastases in stage III colon cancer. Int J Colorectal Dis. 2009;24:1297–302CrossRefPubMed Chin CC, Wang JY, Yeh CY, et al. Metastatic lymph node ratio is a more precise predictor of prognosis than number of lymph node metastases in stage III colon cancer. Int J Colorectal Dis. 2009;24:1297–302CrossRefPubMed
22.
go back to reference Zare Mirzaei A, Abdorrazaghi F, Lotfi M, et al. Prognostic value of lymph node ratio in comparison to lymph node metastases in stage III colon cancer. Iran J Pathol. 2015;10:127–35PubMedPubMedCentral Zare Mirzaei A, Abdorrazaghi F, Lotfi M, et al. Prognostic value of lymph node ratio in comparison to lymph node metastases in stage III colon cancer. Iran J Pathol. 2015;10:127–35PubMedPubMedCentral
23.
go back to reference Smith DD, Schwarz RR, Schwarz RE: Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol. 2005;23:7114–24CrossRefPubMed Smith DD, Schwarz RR, Schwarz RE: Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol. 2005;23:7114–24CrossRefPubMed
24.
go back to reference Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471–4CrossRefPubMed Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471–4CrossRefPubMed
25.
go back to reference Sloothaak DAM, van der Linden RLA, van de Velde CJH, et al. Prognostic implications of occult nodal tumour cells in stage I and II colon cancer: the correlation between micrometastasis and disease recurrence. Eur J Surg Oncol. 2017;43:1456–1462CrossRefPubMed Sloothaak DAM, van der Linden RLA, van de Velde CJH, et al. Prognostic implications of occult nodal tumour cells in stage I and II colon cancer: the correlation between micrometastasis and disease recurrence. Eur J Surg Oncol. 2017;43:1456–1462CrossRefPubMed
26.
27.
go back to reference McDonald JR, Renehan AG, O’Dwyer ST, et al. Lymph node harvest in colon and rectal cancer: current considerations. World J Gastrointest Surg. 2012;4:9–19CrossRefPubMedPubMedCentral McDonald JR, Renehan AG, O’Dwyer ST, et al. Lymph node harvest in colon and rectal cancer: current considerations. World J Gastrointest Surg. 2012;4:9–19CrossRefPubMedPubMedCentral
28.
go back to reference Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003;21:2912–9CrossRefPubMed Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003;21:2912–9CrossRefPubMed
29.
go back to reference Zhou Y, Zhang J, Cao S, et al. The evaluation of metastatic lymph node ratio staging system in gastric cancer. Gastric Cancer. 2013;16:309–17CrossRefPubMed Zhou Y, Zhang J, Cao S, et al. The evaluation of metastatic lymph node ratio staging system in gastric cancer. Gastric Cancer. 2013;16:309–17CrossRefPubMed
30.
go back to reference Marchet A, Mocellin S, Ambrosi A, et al. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series. Eur J Surg Oncol. 2008;34:159–65CrossRefPubMed Marchet A, Mocellin S, Ambrosi A, et al. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series. Eur J Surg Oncol. 2008;34:159–65CrossRefPubMed
Metadata
Title
Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group
Authors
Alexandra G. Lopez-Aguiar, MD, MS
Mohammad Y. Zaidi, MD, MS
Eliza W. Beal, MD
Mary Dillhoff, MD
John G. D. Cannon, MD
George A. Poultsides, MD
Zaheer S. Kanji, MD
Flavio G. Rocha, MD
Paula Marincola Smith, MD
Kamran Idrees, MD
Megan Beems, MD
Clifford S. Cho, MD
Alexander V. Fisher, MD
Sharon M. Weber, MD
Bradley A. Krasnick, MD
Ryan C. Fields, MD
Kenneth Cardona, MD
Shishir K. Maithel, MD
Publication date
01-08-2019
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 8/2019
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07367-y

Other articles of this Issue 8/2019

Annals of Surgical Oncology 8/2019 Go to the issue